Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-29
2007-05-29
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S544000
Reexamination Certificate
active
10778985
ABSTRACT:
The present invention relates to bicyclic heterocycles of general formulawhereinRa, Rb, Rc, Rd, Reand X are defined as in claim1, the tautomers, the stereoisomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids, which have valuable pharmacological properties, particularly an inhibitory effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumoral diseases and benign prostatic hyperplasia (BPH), diseases of the lungs and respiratory tract, and the preparation thereof.
REFERENCES:
patent: 5866572 (1999-02-01), Barker et al.
patent: 6127374 (2000-10-01), Bridges
patent: 6153617 (2000-11-01), Bridges
patent: 6251912 (2001-06-01), Wissner et al.
patent: 6344459 (2002-02-01), Bridges et al.
patent: 6384035 (2002-05-01), Hutchings et al.
patent: 6627634 (2003-09-01), Himmelsbach et al.
patent: 6653305 (2003-11-01), Himmelsbach et al.
patent: 6673803 (2004-01-01), Thomas et al.
patent: 7019012 (2006-03-01), Himmelsbach et al.
patent: 2001/0044435 (2001-11-01), Himmelsbach et al.
patent: 2002/0032208 (2002-03-01), Lohmann et al.
patent: 2002/0077330 (2002-06-01), Himmelsbach et al.
patent: 2002/0169180 (2002-11-01), Himmelsbach et al.
patent: 2002/0173509 (2002-11-01), Himmelsbach et al.
patent: 2002/0177601 (2002-11-01), Himmelsbach et al.
patent: 2003/0149062 (2003-08-01), Jung et al.
patent: 2003/0191308 (2003-10-01), Hennequin et al.
patent: 2004/0024019 (2004-02-01), Tanimoto et al.
patent: 19908567 (1999-02-01), None
patent: 19911366 (1999-03-01), None
patent: 10042060 (2002-03-01), None
patent: 0566226 (1993-10-01), None
patent: WO9520045 (1995-07-01), None
patent: WO9630347 (1996-10-01), None
patent: WO9633980 (1996-10-01), None
patent: WO9702266 (1997-01-01), None
patent: WO9738983 (1997-10-01), None
patent: WO9843960 (1998-10-01), None
patent: WO9906378 (1999-02-01), None
patent: WO9906396 (1999-02-01), None
patent: WO9909016 (1999-02-01), None
patent: WO9935146 (1999-07-01), None
patent: WO0018740 (2000-04-01), None
patent: WO0031068 (2000-06-01), None
patent: WO0051991 (2000-09-01), None
patent: WO0055141 (2000-09-01), None
patent: WO0078735 (2000-12-01), None
patent: WO0177104 (2001-10-01), None
patent: WO 02/50043 (2002-06-01), None
Ulrich, L. et al; Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplidied gene in A431 epidermoid carcinoma cells, “NATURE” vol. 309, May 1984, 418-425.
International Search Report Reference No. PCT/EP 2004/001398.
Tsou, H. et al: 6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity; J. Med. Chem. 2001; vol. 44, pp. 2719-2734.
Himmelsbach Frank
Solca Flavio
Boehringer Ingelheim International GmbH
Devlin Mary-Ellen M.
Grazier Nyeemah
McKane Joseph K.
Morris Michael P.
LandOfFree
Bicyclic heterocycles, pharmaceutical compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic heterocycles, pharmaceutical compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic heterocycles, pharmaceutical compositions... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3773940